B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

WDR77

MOLECULAR TARGET

WD repeat domain 77

UniProt: Q9BQA1NCBI Gene: 790843 compounds

WDR77 (WD repeat domain 77) is targeted by 3 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting WDR77

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1s adenosylhomocysteine1.102
2same0.691
3s adenosylmethionine0.691

About WDR77 as a Drug Target

WDR77 (WD repeat domain 77) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 3 compounds with documented WDR77 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

WDR77 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.